In the past decade Central and Eastern Europe has become a more and more popular place for conducting clinical trials. We give you a balanced picture regarding the key benefits, advantages and risks of the CEE region. Basic regulatory information will also be provided with highlight on the distinct expectations of the authorities in CEE. This webinar is an essential tool of the Clinical Trial Managers and Director level professionals planning or currently running clinical trials in CEE. For more information, please, click here.
HungaroTrial has introduced a webinar series for spring 2013 that will address relevant industry issues and topics with a focus on the Central and Eastern European region. The second topic covers pulmonology clinical trials in the region with an emphasis on cystic fibrosis, asthma, and COPD. Regional experts, including Dr. Janos Mucsi MD, will go into detail on these subjects and provide local knowledge and international experience. For more information, please, click here.
In the current life science industry climate we have recognised a growth in the field of endovascular procedures. There are new methods in the treatment of acute stroke, coronary disease or peripheral arterial occlusion (PAO). Central and Eastern Europe is the front runner in these development programs. Learn more about the opportunities during our webinar! For more information, please, click here.
Increasingly, medical device companies are exploring study opportunities in Central and Eastern Europe. What are their reasons for bringing studies to the region? How well can these countries accomodate First-in-Man and pilot medical device studies? Answers will be provided by HungaroTrial CRO, one of the pioneers of medical device studies in Central and Eastern Europe.For more information, please, click here.
Paediatrics often present a daunting task in the biotech and pharma sectors as many sponsors find dificulty in laying the course for these types of studies. What are the difficulties a sponsor could face with this type of study? Are regulatory procedures different than for studies with adult patients? Dr. Klaus Rose will use his extensive experience in the field to help understand how to initiate a study with ease. For more information, please, click here.
Many of the US based and Westen European companies are seeking treatment naive patients in Central and Eastern Europe. Are they in the right place? What is the standard oncology care in CEE? Does social security cover the costs of the standard control arm of your clinical study? Answers will be provided by one of the most experienced clinical research physicians of the region. For more information, please, click here.
